150 results on '"Ramdhani, Ritesh"'
Search Results
2. Why are clinical trials of deep brain stimulation terminated? An analysis of clinicaltrials.gov
3. An Institutional Experience of Directional Deep Brain Stimulation and a Review of the Literature
4. COVID19-associated new-onset movement disorders: a follow-up study
5. Dysregulation of mitochondrial and proteolysosomal genes in Parkinson’s disease myeloid cells
6. Deep brain stimulation of the subthalamic nucleus for Parkinson’s disease: A network imaging marker of the treatment response
7. Assessment of lmage-guided Programming (IGP) on Bilateral STN and GPi Deep Brain Stimulation Programming Time (P1-3.003)
8. Real-world Outcomes Using DBS Systems with Directionality and Multiple Independent Current Control: USA Experience (P1-3.007)
9. Response to: “Directional Deep Brain Stimulation in Parkinson’s Disease and Essential Tremor: A Retrospective Analysis”
10. Speech Intelligibility during Clinical and Low Frequency
11. Machine learning model comparison for freezing of gait prediction in advanced Parkinson's disease.
12. Differential Responses to Low- and High-Frequency Subthalamic Nucleus Deep Brain Stimulation on Sensor-Measured Components of Bradykinesia in Parkinson's Disease.
13. EP013 / #143 IMPACT OF IMAGE-GUIDED PROGRAMMING (IGP) ON INITIAL DBS CLINIC VISIT TIMES AND OUTCOMES
14. Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendinous xanthomatosis
15. Optimizing Patient-Specific Medication Regimen Policies Using Wearable Sensors in Parkinson’s Disease
16. Differential spatiotemporal gait effects with frequency and dopaminergic modulation in STN-DBS
17. Stratifying Parkinson’s Patients With STN-DBS Into High-Frequency or 60 Hz-Frequency Modulation Using a Computational Model
18. Common Neurologic Issues
19. P142: Efficacy, safety and tolerability of chenodeoxycholic acid in adult patients with cerebrotendinous xanthomatosis (RESTORE): A randomized, placebo-controlled phase 3 study*
20. Treatment of Essential Tremor: Surgical Therapy
21. Neural correlates of abnormal sensory discrimination in laryngeal dystonia
22. Real-World Outcomes in USA using DBS Systems with Directionality and Multiple Independent Current Control (P5-11.017)
23. Image-Guided Programming Tool for DBS Programming Used with a Multiple-Source, Constant-Current System Reduces Initial Programming Time (P4-11.012)
24. Early Use of 60 Hz Frequency Subthalamic Stimulation in Parkinson’s Disease: A Case Series and Review
25. Editorial: Advancing the treatment landscape in Parkinson's disease using sensor technology and data-driven modeling
26. PO269 / #622 PROGRAMMING TIME AND THE USE OF A VISUALIZATION TOOL FOR DBS PROGRAMMING OF A MULTIPLE-SOURCE, CONSTANT-CURRENT SYSTEM
27. ID: 318062 Assessment of lmage-Guided Programming (IGP) on Bilateral STN and GPi Deep Brain Stimulation Programming Time
28. ID: 309438 Real-World Outcomes Using DBS Systems With Directionality and Multiple Independent Current Control: USA Experience
29. P070 REAL-WORLD OUTCOMES USING DBS SYSTEMS WITH DIRECTIONALITY AND MULTIPLE INDEPENDENT CURRENT CONTROL: USA EXPERIENCE
30. ID:16220 Visualization Tool for DBS Programming Used With a Multiple-Source, Constant-Current System Reduces Initial Programming Time
31. †Evaluation of Chenodeoxycholic Acid Treatment in Adult Patients with Cerebrotendinous Xanthomatosis: A Randomized, Placebo-Controlled Phase 3 Study
32. Programming Time and the Use of a Visualization Tool for DBS Programming of a Multiple-Source, Constant-Current System (P5-11.006)
33. A Case of Hemichorea-Hemiballism Following a Cortical Stroke from Occlusion of an Anomalous Accessory Middle Cerebral Artery (P3-10.003)
34. Isolated Focal Dystonia as a Disorder of Large-Scale Functional Networks
35. Common Neurologic Issues
36. Dystonia
37. Whatʼs special about task in dystonia? A voxel-based morphometry and diffusion weighted imaging study
38. P056 ASSESSMENT OF IMAGE-GUIDED PROGRAMMING (IGP) ON BILATERAL STN AND GPI DEEP BRAIN STIMULATION PROGRAMMING TIME
39. Improving Medication Regimen Recommendation for Parkinson’s Disease Using Sensor Technology
40. Opsoclonus-Myoclonus-Ataxia Syndrome Related to the Novel Coronavirus (COVID-19)
41. ID: 197800 Image-Guided Programming Reduces Initial DBS Programming Time in Parkinson's Disease Patients
42. ID: 197975 Real-World Outcomes Using DBS Systems With Directionality and Multiple Independent Current Control: USA Experience
43. Predicting Parkinson’s Disease Medication Regimen Using Sensor Technology
44. Machine Learning’s Application in Deep Brain Stimulation for Parkinson’s Disease: A Review
45. Discordant transcriptional signatures of mitochondrial genes in Parkinson’s disease human myeloid cells
46. Optimizing Individualized Treatment Planning for Parkinson’s Disease Using Deep Reinforcement Learning
47. Opsoclonus-myoclonus Syndrome associated with West Nile Encephalitis (2530)
48. Speech Intelligibility During Clinical and Low Frequency
49. Speech Intelligibility During Clinical and Low Frequency Subthalamic Nucleus Stimulation in Parkinson’s Disease
50. Optimizing Clinical Assessments in Parkinson's Disease Through the Use of Wearable Sensors and Data Driven Modeling
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.